Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.07 - Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
11:35 - 11:45 | Presenter: Juergen Wolf | Author(s): Åslaug Helland, In-Jae Oh, Maria Rita Migliorino, Rafal Dziadziuszko, Javier De Castro Carpeno, Julien Mazieres, Frank Griesinger, Marijana Chlistalla, Andres Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanovic, Silvia Novello
- Abstract
Loading...
-
+
ES06 - New Approaches in Second Line Treatment In NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Susana Cedres, Oliver Gautschi
-
+
ES06.04 - The Best Treatment Sequence for Advanced NSCLC EGFR/ALK/ROS/BRAF wt
14:30 - 14:50 | Presenter: Juergen Wolf
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.01 - A Phase I/II Trial of Dasatinib and Osimertinib in TKI Naïve Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
15:15 - 15:20 | Presenter: Chul Kim | Author(s): Stephen V. Liu, Jeanette Crawford, Deepa S Subramaniam, Guiseppe Giaccone
- Abstract
Loading... -
+
MA09.02 - In Vivo, Ex Vivo and Early Clinical Activity of EGFR Monoclonal Antibody and Osimertinib in EGFR Exon 20 Insertion NSCLC
15:20 - 15:25 | Presenter: Jonathan Wesley Riess | Author(s): Nicolas Floch, Philip C. Mack, Matthew J. Martin, Daniel Vang, Paul D. Smith, Darren Cross, Mingshan Cheng, James Keck, Susan Groshen, Michael Rabin, Sukhmani Padda, Geoffrey R Oxnard, Jacob Sands, Kavitha Ramchandran, Mariana Koczywas, Jeffrey A. Moscow, Pasi A Jänne, Primo N. Lara, Edward Newman, David R Gandara
- Abstract
Loading... -
+
MA09.03 - Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)
15:25 - 15:30 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Yasir Elamin, Brett Carter, Mehmet Altan, Don Lynn Gibbons, Frank Fossella, George R Simon, Vincent Lam, George Blumenschein Jr, Anne Tsao, Jonathan Kurie, Frank E Mott, Marcelo Vailati Negrao, Limei Hu, Junqin He, Monique Nilsson, Brent Roeck, Zane Yang, Vassiliki A Papadimitrakopoulou, John Victor Heymach
- Abstract
Loading... -
+
MA09.04 - Discussant - MA09.01, MA09.02, MA09.03
15:30 - 15:45 | Presenter: Juergen Wolf
- Abstract
No abstract available for this presentation
-
+
MA09.05 - Genomic Correlates of Differential Response to EGFR-Directed Tyrosine Kinase Inhibitors
15:45 - 15:50 | Presenter: Natalie Vokes | Author(s): Tom Nguyen, Christine A Lydon, Emily Chambers, Lynette M Sholl, Mizuki Nishino, Eliezer M Van Allen, Pasi A Jänne
- Abstract
Loading... -
+
MA09.06 - Adaptive Mechanisms of Resistance to Targeted Therapy in EGFR Mutant Brain Metastasis
15:50 - 15:55 | Presenter: Don X. Nguyen | Author(s): Sally Adua, Minghui Zhao, Darren Cross, Paul Smith
- Abstract
Loading... -
+
MA09.07 - Activity of Larotrectinib in TRK Fusion Lung Cancer
15:55 - 16:00 | Presenter: Anna F Farago | Author(s): Shivaani Kummar, Victor Moreno, Jyoti D Patel, Ulrik Lassen, Lee Rosen, Nora C. Ku, Michael C. Cox, Shivani Nanda, Barrett H. Childs, David M. Hyman, Alexander Drilon
- Abstract
Loading... -
+
MA09.08 - Discussant - MA09.05, MA09.06, MA09.07
16:00 - 16:15 | Presenter: Ana Vivancos
- Abstract
No abstract available for this presentation
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading... -
+
MA09.10 - Comprehensive Analysis of Secondary Mutation as Resistance Mechanism to Seven MET-TKIs for MET Exon 14 Skipping in Vitro
16:20 - 16:25 | Presenter: Toshio Fujino | Author(s): Yoshihisa Kobayashi, Kenichi Suda, Takamasa Koga, Masaya Nishino, Shuta Ohara, Masato Chiba, Akira Hamada, Toshiki Takemoto, Junichi Soh, Tetsuya Misudomi
- Abstract
Loading... -
+
MA09.11 - Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Gonzalo Recondo Jr. | Author(s): Magda Bahcall, Lynette M Sholl, Giulia Constanza Leonardi, Biagio Ricciuti, Tom Nguyen, Deepti Venkatraman, Giuseppe Lamberti, Renato Umeton, Pasi A Jänne, Mark Awad
- Abstract
Loading... -
+
MA09.12 - Discussant - MA09.09, MA09.010, MA09.11
16:30 - 16:45 | Presenter: Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-46 - Genetic Testing Patterns, Treatment Characteristics, and Overall Survival in ALK-Positive Metastatic NSCLC Patients Treated with Ceritinib
09:45 - 09:45 | Presenter: Julien Mazieres | Author(s): Myung-Ju Ahn, Christos Chouaid, Anna Kron, Juergen Wolf, Ravi K. Goyal, Keith L Davis, Maurice Perrinjaquet, Timothy Pham, Stefanie Knoll
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.01 - Clinical and Genomic Features of Chinese Lung Cancer Patients with Germline Mutations
15:45 - 15:50 | Presenter: Wenying Peng | Author(s): Jin Li, Lian-peng Chang, Jing Bai, Yanyan Zhang, Yan-Fang Guan, Xingxiang Pu, Meilin Jiang, Jun Cao, Bolin Chen, Xuefeng Xia, Xin Yi, Jianjun Zhang, Lin Wu
- Abstract
Loading... -
+
MA14.02 - Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases
15:50 - 15:55 | Presenter: Luis Paz-Ares | Author(s): Rafal Dziadziuszko, Alexander Drilon, Tom John, Matthew G Krebs, George Demetri, Alice T. Shaw, Salvatore Siena, Juergen Wolf, Anna F Farago, Brian Simmons, Chenglin Ye, Xinhui Huang, Robert C. Doebele
- Abstract
Loading... -
+
MA14.03 - EGFR M+ Subgroup of Phase 1b Study of Telisotuzumab Vedotin (Teliso-V) Plus Erlotinib in c-Met+ Non-Small Cell Lung Cancer
15:55 - 16:00 | Presenter: D. Ross Camidge | Author(s): Fabrice Barlesi, Jonathan Goldman, Daniel Morgensztern, Rebecca S Heist, Everett E. Vokes, Alex Spira, Eric Angevin, Wu-Chou Su, David S. Hong, John H. Strickler, Monica Motwani, Zhaowen Sun, Apurvasena Parikh, Philip Komarnitsky, Jun Wu, Karen Kelly
- Abstract
Loading... -
+
MA14.04 - Discussant - MA14.01, MA14.02, MA14.03
16:00 - 16:15 | Presenter: Yuichiro Ohe
- Abstract
No abstract available for this presentation
-
+
MA14.05 - A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)
16:15 - 16:20 | Presenter: Shun Lu | Author(s): Gongyan Chen, yuping Sun, sanyuan Sun, Jianhua Chang, yu Yao, Zhendong Chen, feng Ye, Junguo Lu, Jianhua Shi, Jianxing He, xiaoqing Liu, Yiping Zhang, zhihua Liu, Jian Fang, Ying Cheng, chunhong Hu, weidong Mao, Yanping Hu, Youling Gong, Li Shan, zhixiong Yang, Yong Song, wei Li, chong Bai, buhai Wang, rui Ma, zhendong Zheng, mingfang Liu, zhijun Jie, Lejie Cao, wangjun Liao, Hongming Pan, dongning Huang, Yuan Chen, jinji Yang, shukui Qin, Shenglin Ma, Li Liang, zhe Liu, Jianying Zhou, Min Tao, yijiang Huang, feng Qiu, yunchao Huang, Ye Hua, yiping Chen, weiguo Su
- Abstract
Loading... -
+
MA14.06 - Nintedanib-Docetaxel in 2nd Line Treatment in No Squamous Non-Small Cell Lung Cancer Patients, Refractory to First Line Treatment (GFPC02-15)
16:20 - 16:25 | Presenter: Alain Vergnenegre | Author(s): Jean Bernard Auliac, Isabelle Monnet, acya Bizieux, Laurent Greillier, Lionel Falchero, Gilles Robinet, Regien Lamy, Pierre-Alexandre Hauss, Florian Guisier, Hervé Lena, Christos Chouaid
- Abstract
Loading... -
+
MA14.07 - Phase I Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naïve Non-Small Cell Lung Cancer (JVDF)
16:25 - 16:30 | Presenter: Roy S. Herbst | Author(s): Hendrik Tobias Arkenau, Johanna Bendell, Edward Arrowsmith, Martin Wermke, Andres Soriano, Nicolas Penel, Rafael Santana-Davila, Helge Bischoff, Ian Chau, Bo Chao, David Ferry, Gu Mi, Luis Paz-Ares
- Abstract
Loading... -
+
MA14.08 - Discussant - MA14.05, MA14.06, MA14.07
16:30 - 16:45 | Presenter: Mirjana Rajer
- Abstract
No abstract available for this presentation
-
+
MA14.09 - Real-World Survival of Relapsed Compared to De-Novo Stage IV Diagnosis of Advanced Non-Small Cell Lung Cancer
16:45 - 16:50 | Presenter: Katie Kerrigan | Author(s): Benjamin Haaland, Blythe Adamson, Shiven Patel, Wallace Akerley
- Abstract
Loading... -
+
MA14.10 - Clinical Outcomes in Metastatic Squamous Lung Cancer with Targetable Driver Alterations
16:50 - 16:55 | Presenter: Whitney Elizabeth Lewis | Author(s): George R Simon, Frank E Mott, Vassiliki A Papadimitrakopoulou, Waree Rinsurongkawong, Jeff Lewis, Jack Lee, Jack Roth, Stephen Swisher, John Victor Heymach, Jianjun Zhang, Vincent Lam
- Abstract
Loading... -
+
MA14.11 - CareTrack: An Application-Based Method of Documentation for Improving Patient Communication in Cancer Care
16:55 - 17:00 | Presenter: Jawaid Younus | Author(s): Jacques Raphael, Phillip Blanchette, Fahad Khan, Vineet Sharma, Morgan Black, Mark Vincent, Sara Kuruvilla, Michael Sanatani
- Abstract
Loading... -
+
MA14.12 - Discussant - MA14.09, MA14.10, MA14.11
17:00 - 17:15 | Presenter: Virginie Westeel
- Abstract
No abstract available for this presentation
-
+
IS16 - Symposium by Novartis: The Road Ahead: New Horizons In The Treatment Of NSCLC (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/10/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
OA15 - Targeted Agents and Immunotherapy for Small Cell Lung Cancer
- 14:30 - 16:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Raffaele Califano, Charles M Rudin
-
+
OA15.05 - BIOLUMA: A Phase II Trial of Nivolumab and Ipilimumab in Lung Cancer – Prospective Evaluation of TMB in SCLC Patients
15:15 - 15:25 | Presenter: Julie George | Author(s): Rieke Nila Fischer, Andreas H Scheel, Hans Schlösser, Maria Vehreschild, Diana S.Y. Abdulla, Sophia Koleczko, Sebastian Michels, Lucia Nogova, Richard Riedel, Matthias Scheffler, Lukas Maas, Peter Brossart, Walburga Engel-Riedel, Frank Griesinger, Christian Grohé, Jens Kern, Barbara Hermes, Kathrin Nachtkamp, Jens Peter Panse, Martin Sebastian, Markus Lehmann, Rainer Gerhard Wiewrodt, Reinhard Buettner, Roman Thomas, Juergen Wolf
- Abstract
As requested by the author, the abstract for this presentation will not be published